[文献资料]参 考 文 献

ESMO Guideliness Task Force . ESMO minimum clinical recommendations for diagnosis ， adjuvant treatment and follow-up of primary breast cancer .Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced ， inflammatory ， or ......